These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35653914)

  • 41. The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex.
    van Harten B; Laman DM; van Duijn H; Knol DL; Stam CJ; Scheltens P; Weinstein HC
    Dement Geriatr Cogn Disord; 2006; 21(5-6):322-7. PubMed ID: 16484811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vascular dementia and vascular cognitive impairment].
    Qian CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):198-200. PubMed ID: 15171562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive and neuroimaging markers for preclinical vascular cognitive impairment.
    Lowry E; Puthusseryppady V; Johnen AK; Renoult L; Hornberger M
    Cereb Circ Cogn Behav; 2021; 2():100029. PubMed ID: 36324708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation.
    Lanza G; Bramanti P; Cantone M; Pennisi M; Pennisi G; Bella R
    Behav Neurol; 2017; 2017():1421326. PubMed ID: 28348458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment.
    Rajeev V; Fann DY; Dinh QN; Kim HA; De Silva TM; Lai MKP; Chen CL; Drummond GR; Sobey CG; Arumugam TV
    Theranostics; 2022; 12(4):1639-1658. PubMed ID: 35198062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Characteristics of cognitive impairment in adults with cerebral ischemia].
    Lei Y; Guo Q; Li Y; Jiang H; Ni W; Gu Y
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):984-9. PubMed ID: 24851684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder.
    Isernia S; Cabinio M; Di Tella S; Pazzi S; Vannetti F; Gerli F; Mosca IE; Lombardi G; Macchi C; Sorbi S; Baglio F
    J Alzheimers Dis; 2021; 83(4):1789-1801. PubMed ID: 34459394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular Cognitive Impairment.
    Graff-Radford J
    Continuum (Minneap Minn); 2019 Feb; 25(1):147-164. PubMed ID: 30707191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular cognitive impairment: disease mechanisms and therapeutic implications.
    Levine DA; Langa KM
    Neurotherapeutics; 2011 Jul; 8(3):361-73. PubMed ID: 21556678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
    Cysique LA; Brew BJ
    J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Stress Hyperglycemia after Ischemic Stroke with Early Vascular Cognitive Impairment.
    Zhou YD; Yuan HW; Ji RJ; Luo BY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Dec; 39(6):749-755. PubMed ID: 29338817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new diagnostic algorithm for vascular cognitive impairment: the proposed criteria and evaluation of its reliability and validity.
    Zhao QL; Zhou Y; Wang YL; Dong KH; Wang YJ
    Chin Med J (Engl); 2010 Feb; 123(3):311-9. PubMed ID: 20193251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding and treating vascular cognitive impairment.
    Gorelick PB; Nyenhuis D
    Continuum (Minneap Minn); 2013 Apr; 19(2 Dementia):425-37. PubMed ID: 23558487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.
    Kalaria RN
    Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenesis and treatment of vascular cognitive impairment.
    Jellinger KA
    Neurodegener Dis Manag; 2014; 4(6):471-90. PubMed ID: 25531689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular dementia.
    Erkinjuntti T; Rockwood K
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):37-45. PubMed ID: 12567331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.
    Chua XY; Chai YL; Chew WS; Chong JR; Ang HL; Xiang P; Camara K; Howell AR; Torta F; Wenk MR; Hilal S; Venketasubramanian N; Chen CP; Herr DR; Lai MKP
    Alzheimers Res Ther; 2020 Sep; 12(1):122. PubMed ID: 32998767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.